A woman from New York recently filed a Bayer Essure lawsuit alleging she sustained permanent injuries after using Essure implants.

The Bayer Essure lawsuit alleges the permanent birth control had caused severe and permanent injuries to the claimant due to risks she says were not sufficiently discussed on the warning label.

Plaintiff Lisa B. filed this Bayer Essure lawsuit soon after discovering numerous other women had reported serious reproductive injuries from the permanent contraceptive, and that Bayer allegedly knew about these devastating problems for years.

According to the Bayer Essure lawsuit, Lisa had the Essure birth control device implanted on April 9, 2011. At a follow-up appointment, her physician confirmed that the implants were preventing pregnancy, she says.

However, the Bayer Essure lawsuit alleges Lisa started suffering a multitude of complications after the device was implanted including unusual bleeding, pain and cramping, abnormal periods, and painful intercourse. She says these symptoms eventually became so bad that she had to undergo a left oophorectomy, or removal of her left ovary.

Lisa opted to file the Bayer Essure lawsuit soon after learning about problems with the permanent birth control device in spring 2018, when she learned that Bayer would be taking the Essure off the market at the end of 2018.

Overview of Bayer Essure Lawsuit

The Essure permanent birth control device consists of two metal coils made of a nickel alloy, which are implanted into each fallopian tube. The coils are designed to spur growth of scar tissue in the fallopian tubes, which permanently prevents sperm to egg fertilization.

The Essure coils have been the only non surgical treatment method for female sterilization in the United States. They became very popular after their release in 2002.

Bayer marketed the permanent contraceptive by focusing on its convenience. Implantation with Essure involved a minimally invasive implant procedure and fast recovery time.

Lisa says she relied on the product brochure provided by Bayer that stated the contraceptive was safe and effective for female sterilization. However, this has allegedly not been the case for numerous women who have allegedly suffered permanent injuries to their reproductive health.

According to an FDA announcement in April 2018, all women considering the device and their prescribing physician were ordered to fill out a “Patient Decision Checklist” or Risk Acknowledgment Form, to confirm they were aware of the severity of the potential device complications.

Even with these precautions, women were still reportedly suffering serious Essure complications. Bayer recently announced that it would cease selling the Essure birth control device in the U.S. on Dec. 31, 2018.

Lisa states she would not have agreed to have the Essure birth control device implanted if she had been aware of the allegedly defective nature of the device.

Even though these complications can be devastating to patients, Bayer allegedly failed to warn Lisa and other patients about these problems. Lisa’s Bayer Essure lawsuit is raising several claims including counts of negligence and failure to warn.

This Bayer Essure Lawsuit is Case No. 2:18-cv-05345-PD, in the Court of Common Pleas, Philadelphia County.